Vitamin D Receptor Gene TaqI Polymorphism and Its Impact on Obesity

Obesity is a growing global health concern characterized by excessive body fat accumulation, which is often linked to reduced levels of vitamin D. The vitamin D receptor (VDR) gene has several polymorphisms, including TaqI (rs731236), whose association with obesity has been inconsistent across studies. Understanding these genetic factors is crucial for developing personalized interventions for metabolic health. In a recent study approved by the Research Ethics Committee of the Federal University of Pampa, 275 individuals were assessed based on their Body Mass Index (BMI), categorized into eutrophic, overweight, and obese groups. Blood samples were collected, and 246 individuals underwent genotyping for the VDR gene TaqI polymorphism. The findings revealed that individuals with the CC genotype had significantly higher vitamin D levels compared to those with the TT genotype. Moreover, biochemical parameters such as triglycerides and HDL levels were lower in the obesity group, while inflammatory markers like IL-8, IL-10, and CRP were elevated in both the overweight and obesity groups. Notably, vitamin D emerged as an independent protective factor against obesity-related inflammation, while TaqI polymorphism did not independently predict obesity risk. These findings underscore the importance of monitoring vitamin D levels and inflammation markers in individuals at risk of obesity. For those looking to improve their metabolic health, ensuring adequate vitamin D intake through diet or supplementation could be beneficial. Additionally, lifestyle changes such as adopting a low-carb diet or engaging in regular physical activity can help mitigate inflammation and improve overall metabolic function. The biomarkers relevant to this study include vitamin D, hsCRP, and triglycerides, which can be evaluated using Metabolicum's calculators. Tracking these biomarkers can provide insights into an individual's metabolic health and guide personalized interventions. In conclusion, while TaqI polymorphism may not directly influence obesity risk, the protective role of vitamin D against inflammation highlights its potential as a target for preventive strategies. Individuals should consider monitoring their vitamin D levels and inflammatory markers as part of their metabolic health journey.